Transcription factor 7 (TCF7)

Transcription factor 7 (TCF7) is a T-cell-specific high-mobility group (HMG) box-containing transcription factor that acts as a key regulator of T-cell lineage specification, development, and differentiation. TCF7 can function as a transcriptional activator or repressor, depending on isoform and binding partners—specifically, it activates gene transcription when partnered with beta-catenin in the canonical Wnt signaling pathway and represses transcription when bound by Groucho corepressors. The gene encodes multiple regulatory isoforms through alternative splicing, broadly categorized as full-length activators and dominant-negative repressors. TCF7 is essential for early T-cell specification in the thymus, maturation of innate lymphoid cells, natural killer cells, and regulation of immune response effector functions. Dysregulation of TCF7 is implicated in a range of diseases such as cancer, autoimmunity, and lung pathology. Recent research identifies it as a promising therapeutic target for immunomodulation and cancer treatment, with potential for drug development focused on its interaction with beta-catenin and other co-regulators.

Other names

Transcription factor 7TCF7TCF1TCF-7T-cell factor 1TCF-1T-cell-specific transcription factor 1T-cell-factor-7transcription factor 7 (T-cell specific, HMG-box)

Drugs or agents that disrupt TCF7 and beta-catenin interaction (e.g., aptamers or small molecules) can modulate transcription activity, either activating or repressing Wnt pathway target genes.